Keybank National Association Catalent, Inc. Transaction History

Keybank National Association

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$87.2 - $114.05 $7,499 - $9,808	86 Added 3.56%	2,501 $268,000
Q1 2022 Apr 28, 2022	SELL	$94.19 - $124.49 $18,272 - $24,151	-194 Reduced 7.44%	2,415 $268,000
Q4 2021 Feb 07, 2022	BUY	$119.57 - $139.07 $119 - $139	1 Added 0.04%	2,609 $334,000
Q3 2021 Nov 08, 2021	BUY	$109.17 - $142.35 $27,510 - $35,872	252 Added 10.7%	2,608 $347,000
Q2 2021 Aug 12, 2021	SELL	$100.34 - $115.69 $5,217 - $6,015	-52 Reduced 2.16%	2,356 $255,000
Q1 2021 May 07, 2021	SELL	$101.51 - $125.27 $48,623 - $60,004	-479 Reduced 16.59%	2,408 $254,000
Q4 2020 Feb 09, 2021	SELL	$85.88 - $105.36 $171 - $210	-2 Reduced 0.07%	2,887 $300,000
Q3 2020 Oct 29, 2020	BUY	$72.74 - $92.5 $210,145 - $267,232	2,889 New	2,889 $247,000
Q2 2020 Aug 10, 2020	SELL	$48.02 - $79.04 $217,770 - $358,446	-4,535 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$36.95 - $62.95 $1,699 - $2,895	-46 Reduced 1.0%	4,535 $236,000
Q4 2019 Feb 05, 2020	BUY	$47.06 - $56.64 $3,811 - $4,587	81 Added 1.8%	4,581 $258,000
Q2 2019 Aug 01, 2019	BUY	$39.26 - $54.21 $176,670 - $243,945	4,500 New	4,500 $244,000

118

37.8M

123K

432K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.